Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment

被引:0
|
作者
Axel C. Mühlbacher
John F. P. Bridges
Susanne Bethge
Ch.-Markos Dintsios
Anja Schwalm
Andreas Gerber-Grote
Matthias Nübling
机构
[1] University of Applied Sciences Neubrandenburg,Institute for Health Economics and Health Care Management (IGM)
[2] Duke University,Center for Health Policy and Inequalities Research, Duke Global Health Institute
[3] Johns Hopkins Bloomberg School of Public Health,Department of Health Policy and Management
[4] Institute for Quality and Efficiency in Health Care (IQWiG),Strategic Market Access Intelligence
[5] Bayer Health Care,Department of Public Health, Faculty of Medicine
[6] Heinrich-Heine University,undefined
[7] Empirical Consulting mbH (GEB mbH),undefined
关键词
Discrete choice experiment (DCE); Conjoint analysis (CA); Hepatitis C virus (HCV); Health technology assessment (HTA); Patient preferences; Priority setting; I 11; H 51; I 18;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:155 / 165
页数:10
相关论文
共 50 条
  • [31] EVALUATING PATIENT PREFERENCES OF MAINTENANCE THERAPY FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE UK: A DISCRETE CHOICE EXPERIMENT
    Schroeder, M.
    Lewis, H.
    Doll, H.
    Gunsoy, N. B.
    Llewellyn, S.
    Jones, P. W.
    Ismaila, A. S.
    THORAX, 2018, 73 : A232 - A232
  • [32] Patient preferences and priorities for haemophilia gene therapy in the US: A discrete choice experiment
    Witkop, Michelle
    Morgan, George
    O'Hara, Jamie
    Recht, Michael
    Buckner, Tyler W.
    Nugent, Diane
    Curtis, Randall
    O'Mahony, Brian
    Skinner, Mark W.
    Mulhern, Brendan
    Cawson, Matthew
    Ali, Talaha M.
    Sawyer, Eileen K.
    Li, Nanxin
    HAEMOPHILIA, 2021, 27 (05) : 769 - 782
  • [33] Patients' Preferences for Antiretroviral Therapy Service in Northwest Ethiopia: A Discrete Choice Experiment
    Belay, Yihalem Abebe
    Yitayal, Mezgebu
    Atnafu, Asmamaw
    Taye, Fitalew Agimass
    MDM POLICY & PRACTICE, 2024, 9 (02)
  • [34] Patients' preferences in the therapy of pollen-allergic rhinoconjunctivitis - a discrete choice experiment
    Nuebling, M.
    Schreder, H.
    Karagiannis, E.
    Muehlbacher, A. C.
    ALLERGY, 2014, 69 : 476 - 477
  • [35] Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan
    Timothy Bolt
    Hisanori Kobayashi
    Jörg Mahlich
    PharmacoEconomics - Open, 2019, 3 : 255 - 264
  • [36] EVALUATING PATIENT PREFERENCES OF MAINTENANCE THERAPY FOR THE TREATMENT OF COPD: A DISCRETE CHOICE EXPERIMENT
    Schroeder, Melanie
    Doll, Helen
    Lewis, Hannah
    Gunsoy, Necdet
    Llewellyn, Samuel
    Jones, Paul
    Ismaila, Afisi
    CHEST, 2018, 154 (04) : 769A - 769A
  • [37] Heterogeneous Patient Preferences for Modern Antiretroviral Therapy: Results of a Discrete Choice Experiment
    Ostermann, Jan
    Muehlbacher, Axel
    Brown, Derek S.
    Regier, Dean A.
    Hobbie, Amy
    Weinhold, Andrew
    Alshareef, Noor
    Derrick, Caroline
    Thielman, Nathan M.
    VALUE IN HEALTH, 2020, 23 (07) : 851 - 861
  • [38] Patients' Preferences for Benefits and Risks of Anticoagulant Therapy: A Discrete Choice Experiment (DCE)
    Najafzadeh, Mehdi
    Gagne, Joshua J.
    Choudhry, Niteesh K.
    Polinski, Jennifer M.
    Avorn, Jerry L.
    Schneeweiss, Sebastian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 358 - 359
  • [39] Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan
    Bolt, Timothy
    Kobayashi, Hisanori
    Mahlich, Jorg
    PHARMACOECONOMICS-OPEN, 2019, 3 (02) : 255 - 264
  • [40] Topical problems of antiviral therapy for chronic hepatitis C
    Bakulin, I. G.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (11) : 113 - 117